The anti-inflammatory claim is biologically plausible, and mostly still an animal story.
CB2 receptors sit on immune cells, and activating them reduces inflammatory signaling in preclinical models. The mechanism is real and well-mapped. The leap to "it treats human inflammatory disease" is where the data thins out.
CB2 & immune modulation, PubMed ↗Nabiximols (THC+CBD spray) is approved in many countries for MS-related spasticity, a condition with neuroinflammatory roots. It is the closest the field has come to an inflammation-targeted cannabinoid medicine, and even here the approved indication is symptom control, not disease modification.
Nabiximols & MS spasticity, PubMed ↗For Crohn’s disease and ulcerative colitis, small trials show symptom improvement but no consistent effect on measured inflammation, patients feel better while objective markers barely move. For arthritis, evidence is thinner still.
Cannabis & inflammatory bowel disease, PubMed ↗Combusted cannabis delivers irritants that inflame airways. Anyone exploring cannabinoids for inflammation faces an obvious contradiction if the route is smoking.
Cannabis smoke & airway inflammation, PubMed ↗Cannabis is not an approved treatment for inflammation in most jurisdictions, and nothing here recommends using it. If inflammation affects your life, bring this research, literally, these sources, to a physician and decide together. Laws differ by country and state; check CannabisLaws.ai before anything else.
Is it legal where you live? Tell us your city to see the law status and minimum age.
Status for all 64 jurisdictions on CannabisLaws. Not legal advice.